For Sponsors

Unlock the full potential of your Berlin studies

Support a future where clinical trials recruit faster

This initiative will be the first of its type and creates a scalable model harnessing Berlin’s characteristics, such as its diverse population, strong healthcare infrastructure, and vibrant community networks. This concept will be replicated to other metropolitan cities across the globe.

We raise awareness and drive patient participation in clinical trials across Berlin. Make recruiting studies visible and accessible to the public. Educate and activate patients, HCPs, and communities through a coordinated, city-wide movement incl. “boots on the ground“ and our dedicated OncoConnect innovation.

Why you should support this initiative?

1. Accelerated recruitment & reduced timelines

The initiative increases public and HCP awareness, drives patient interest, and strengthens site performance, all leading to faster “first patient in” and more efficient enrollment, especially in a competitive landscape.

2. Higher patient diversity and retention

Broader outreach across communities in Berlin will lead to more diverse and engaged participants while lowering dropout rates.

3. Enhanced site collaboration

The initiative strengthens Berlin’s sites through branding, operational support, and HCP engagement — which means more trial-ready, motivated, and well-supported sites for sponsors to rely on.

4. Public-private partnership & policy alignment

Supporting the initiative shows alignment with national goals like those outlined in the Medical Research Act (Medizinforschungsgesetz), strengthening the sponsor’s role in shaping the future of clinical research in Germany.

5. Reputation & visibility

Sponsors publicly associated with a socially impactful, patient-centered initiative gain reputation benefits, with patients, physicians, regulators, and their own internal stakeholders. Don’t miss out!

Packages for Sponsors

PLATINUM

Portfolio Listing
Trial Awareness
Reporting & Insights
PR inclusion (full)
Event Access (unlimited)
Co-branding
HCP Ambassadors¹
OncoCONNECT²

GOLD

Portfolio Listing
Trial Awareness
Reporting & Insights
PR inclusion (full)
Event Access (unlimited)
Co-branding
HCP Ambassadors¹
OncoCONNECT²

SILVER

Portfolio Listing
Trial Awareness
Reporting & Insights
PR inclusion (full)
Event Access (unlimited)
Co-branding
HCP Ambassadors¹
OncoCONNECT²

¹Addressing relevant HCPs for your study with local “boots on the ground”
²Dedicated service for your Onco trial to place your studies where the decisions are taken (“tumor boards”). Optimized flow with individual path-way interviews early on. Engage and build trust with treating HCPs via onco-trained experts

Want to be part of the Berlin movement?

Get in touch to see how you can unlock the full potential of your Berlin studies.

How will your studies benefit?

Faster study activation and recruitment in Berlin

Thanks to awareness campaigns, site activation support, and higher patient readiness.

Increased site performance and data quality

Better informed patients and closer site/HCP collaboration reduces screen failures and protocol deviations.

Demonstrated ESG and social responsibility

Participation shows commitment to health equity, access, and local community benefit, key elements of ESG strategy, and public affairs.

Scalable model for other cities

A proven framework that can be extended to other urban centers in Germany or across the world with the sponsor as a founding supporter.

What sponsors think of this project

Embracing city-wide clinical trial awareness isn’t just innovative, it’s essential. As an early adopter of this project, we hope others will join us in transforming how we as an industry engage communities, including those underrepresented. This is an opportunity to not only increase patient enrollment rates in Berlin, but increase the awareness and openness to clinical trials as a treatment option on a much larger scale.

Dr. Michael Busse, Head of Clinical Research,
Boehringer Ingelheim